VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TGEN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TGENTecogen Inc.
$5.23$156M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. TGEN
  4. Financial Ratios

Tecogen Inc. (TGEN) Financial Ratios

Latest Ratios: P/E Ratio -17.4x · EV/EBITDA N/A · ROE -52.2%. (2011–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

TGEN Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$156M$135M$37M$20M$31M$30M$30M$53M$90M$63M$81M
Enterprise Value$147M$125M$35M$20M$30M$28M$32M$57M$92M$62M$80M
P/E Ratio →-17.43————8.00———1350.00—
P/S Ratio5.784.971.620.801.241.241.071.582.511.903.31
P/B Ratio6.636.273.611.371.641.431.762.253.211.875.58
P/FCF——11.82——97.0724.77————
P/OCF——9.00——64.8121.54————

P/E links to full P/E history page with 30-year chart

TGEN EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—4.611.540.811.221.171.151.702.561.873.29
EV / EBITDA—————————76.51—
EV / EBIT—————7.50———246.07—
EV / FCF——11.28——91.7326.49————

TGEN Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin36.3%36.3%43.6%40.6%44.3%47.5%38.3%37.3%37.9%39.0%38.0%
Operating Margin-26.3%-26.3%-20.0%-17.6%-9.4%-5.0%-21.1%-13.9%-15.4%0.7%-4.1%
Net Profit Margin-30.5%-30.5%-21.0%-18.3%-9.8%15.1%-21.8%-14.1%-15.9%0.1%-4.5%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-52.2%-52.2%-38.4%-27.3%-12.2%19.3%-30.3%-18.3%-18.5%0.2%-8.1%
ROA-24.2%-24.2%-16.2%-16.4%-8.1%11.8%-17.3%-10.3%-11.4%0.1%-4.9%
ROIC-52.7%-52.7%-29.3%-20.0%-9.3%-4.7%-19.0%-12.2%-13.3%0.7%-6.3%
ROCE-34.0%-34.0%-28.7%-23.3%-10.6%-5.4%-24.4%-14.5%-14.1%0.7%-5.9%

TGEN Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.130.130.370.100.070.090.210.220.070.030.22
Debt / EBITDA—————————1.05—
Net Debt / Equity—-0.45-0.170.01-0.03-0.080.120.180.06-0.02-0.04
Net Debt / EBITDA—————————-1.01—
Debt / FCF——-0.54——-5.341.73————
Interest Coverage-53.75-53.75-38.71-57.28-143.37100.00-47.22-45.92-47.061.63-5.61

Net cash position: cash ($12M) exceeds total debt ($3M)

TGEN Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio3.123.121.321.942.872.842.522.082.002.493.57
Quick Ratio1.941.940.740.931.501.961.701.601.521.902.72
Cash Ratio1.341.340.320.130.250.410.170.070.020.190.66
Asset Turnover—0.730.730.900.880.750.940.810.720.661.03
Inventory Turnover1.581.581.321.421.331.652.433.273.543.953.18
Days Sales Outstanding—59.58103.68116.06124.37175.64167.14218.29194.07154.84166.34

TGEN Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield—————12.5%———0.1%—
FCF Yield——8.5%——1.0%4.0%————
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Total Shareholder Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Shares Outstanding—$27M$25M$25M$25M$25M$25M$25M$25M$23M$19M

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Persistent negative operating margins

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Market Valuation Reflects Distressed Status

According to recent market data, TGEN trades at a price-to-sales multiple of 5.71, which appears elevated given the company's persistent negative earnings and the lack of a forward P/E ratio, suggesting investors are pricing in speculative recovery potential rather than current fundamental performance.

The negative TTM P/E of -17.23 underscores the absence of bottom-line profitability, making traditional earnings-based valuation metrics inapplicable. The high P/B ratio of 6.56 relative to the company's inability to generate positive returns on equity suggests that the market may be valuing the firm's intellectual property and service infrastructure rather than its current cash-generating capacity.

Capital Efficiency Remains Structurally Impaired

Based on reported financial statements, Tecogen's ROIC has remained consistently negative, reaching -12.8% in 2026Q1, which indicates that the company is currently destroying shareholder value rather than compounding it through its core industrial operations and service network investments.

The persistent negative ROIC trend over the last ten quarters suggests that the capital deployed into the business is not earning a return above the cost of capital. This decay in returns appears driven by the inability to scale revenue sufficiently to cover the fixed costs inherent in the company's specialized service and manufacturing model.

Working Capital Cycles Impede Liquidity

As reported in recent filings, the company's cash conversion cycle reached 252 days in 2026Q1, a figure that highlights significant inefficiencies in inventory management and collection cycles compared to broader industrial peers, placing additional strain on the firm's limited cash resources.

The high days inventory outstanding, which peaked at 346 days in 2024Q2, suggests that the company may be carrying excessive or obsolete parts inventory for its legacy engine fleet. Investors should monitor whether management can optimize these working capital components, as the current cycle length necessitates a larger cash buffer than would otherwise be required.

Liquidity Buffer Masks Operational Fragility

According to the latest balance sheet data, Tecogen maintains a current ratio of 3.02, which provides a superficial appearance of strength, yet this liquidity is heavily tied to inventory and receivables rather than cash, warranting caution regarding the company's ability to meet obligations under stress.

While the quick ratio of 1.72 suggests the company can cover short-term liabilities without relying on inventory liquidation, the persistent cash burn makes this liquidity position a finite resource. The reliance on project-based revenue means that any significant delay in contract milestones could rapidly erode this liquidity buffer.

Misapplication of Revenue-Based Valuation Multiples

Market participants frequently misapply the price-to-sales ratio to Tecogen, which obscures the company's underlying profitability challenges and the high cost of servicing its installed base, leading to an incomplete assessment of the firm's true economic value as an industrial service provider.

Using P/S as a primary valuation metric ignores the fact that a significant portion of revenue is tied to low-margin or project-based equipment sales that do not contribute to long-term cash flow. A more appropriate approach would be to value the recurring service revenue segment separately using a multiple of EBITDA, while treating the product segment as a capital-intensive, non-core activity.

Download Financial Ratios Data

Includes 30+ ratios · 15 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TGEN — Frequently Asked Questions

Quick answers to the most common questions about buying TGEN stock.

What is Tecogen Inc.'s P/E ratio?

Tecogen Inc.'s current P/E ratio is -17.4x. The historical average is 8.0x.

What is Tecogen Inc.'s ROE?

Tecogen Inc.'s return on equity (ROE) is -52.2%. The historical average is -26.3%.

Is TGEN stock overvalued?

Based on historical data, Tecogen Inc. is trading at a P/E of -17.4x. Compare with industry peers and growth rates for a complete picture.

What are Tecogen Inc.'s profit margins?

Tecogen Inc. has 36.3% gross margin and -26.3% operating margin.